In the last trading session, 4.22 million Werewolf Therapeutics Inc (NASDAQ:HOWL) shares changed hands as the company’s beta touched 0.65. With the company’s per share price at $1.02 changed hands at -$0.12 or -10.53% during last session, the market valuation stood at $45.77M. HOWL’s last price was a discount, traded about -309.8% off its 52-week high of $4.18. The share price had its 52-week low at $0.60, which suggests the last value was 41.18% up since then. When we look at Werewolf Therapeutics Inc’s average trading volume, we note the 10-day average is 0.72 million shares, with the 3-month average coming to 440.27K.
Analysts gave the Werewolf Therapeutics Inc (HOWL) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended HOWL as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Werewolf Therapeutics Inc (NASDAQ:HOWL) trade information
Instantly HOWL was in red as seen at the end of in last trading. With action -14.29%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -56.41%, with the 5-day performance at -14.29% in the red. However, in the 30-day time frame, Werewolf Therapeutics Inc (NASDAQ:HOWL) is -16.39% down. Looking at the short shares, we see there were 1.84 million shares sold at short interest cover period of 2.57 days.
The consensus price target for the stock as assigned by Wall Street analysts is 12, meaning bulls need an upside of 91.5% from its current market value. According to analyst projections, HOWL’s forecast low is 12 with 12 as the target high. To hit the forecast high, the stock’s price needs a -1076.47% plunge from its current level, while the stock would need to soar -1076.47% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -20.76%. The 2025 estimates are for Werewolf Therapeutics Inc earnings to decrease by -6.99%, but the outlook for the next 5-year period is at -3.68% per year.
HOWL Dividends
Werewolf Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-08.
Werewolf Therapeutics Inc (NASDAQ:HOWL)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 6.07% of Werewolf Therapeutics Inc shares while 62.74% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 66.80%. There are 62.74% institutions holding the Werewolf Therapeutics Inc stock share, with RA CAPITAL MANAGEMENT, L.P. the top institutional holder. As of 2024-06-30, the company held 14.7688% of the shares, roughly 6.14 million HOWL shares worth $14.99 million.
MPM ASSET MANAGEMENT LLC holds the second largest percentage of outstanding shares, with 10.2967% or 4.28 million shares worth $10.45 million as of 2024-06-30.